Stephen Mahoney
2023 - Dianthus Therapeutics
In 2023, Stephen Mahoney earned a total compensation of $1.7M as Former President, Chief Financial and Operating Officer at Dianthus Therapeutics, a 48% increase compared to previous year.
Compensation breakdown
| Bonus | $539,134 |
|---|---|
| Option Awards | $118,285 |
| Salary | $309,257 |
| Other | $690,000 |
| Total | $1,656,676 |
Mahoney received $690K in other compensation, accounting for 42% of the total pay in 2023.
Mahoney also received $539.1K in bonus, $118.3K in option awards and $309.3K in salary.
Rankings
In 2023, Stephen Mahoney's compensation ranked 646th out of 2,447 executives tracked by ExecPay. In other words, Mahoney earned more than 73.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 646 out of 2,447 | 74th |
Division Manufacturing | 360 out of 1,337 | 73rd |
Major group Chemicals And Allied Products | 245 out of 752 | 67th |
Industry group Drugs | 241 out of 720 | 67th |
Industry Pharmaceutical Preparations | 155 out of 511 | 70th |
Source: SEC filing on April 11, 2024.
Mahoney's colleagues
We found six more compensation records of executives who worked with Stephen Mahoney at Dianthus Therapeutics in 2023.
2023
Thomas Beetham
Dianthus Therapeutics
Chief Legal Officer
2023
Lisa Olson
Dianthus Therapeutics
Chief Scientific Officer
2023
Jason Gardner
Dianthus Therapeutics
Chief Executive Officer
2023
Marino Garcia
Dianthus Therapeutics
Chief Executive Officer
2023
Simrat Randhawa
Dianthus Therapeutics
Chief Medical Officer
2023
Ryan Savitz
Dianthus Therapeutics
Chief Financial Officer
News
Signal Genetics CEO Scott Myers receives $36M in 2023
April 26, 2024
Dianthus Therapeutics Former President, Chief Financial and Operating Officer Stephen Mahoney's 2023 pay jumps 48% to $1.7M
April 11, 2024
Kiniksa Pharmaceuticals, Ltd. CEO Sanj Patel's 2019 pay falls 35% to $4.8M
April 28, 2020
Kiniksa Pharmaceuticals, Ltd. CEO Sanj Patel's 2018 pay jumps 389% to $7.3M
April 17, 2019